Indigo Diabetes NV

Medical Devices & EquipmentSeries BGent, Belgiumindigomed.com

Latest round

Series B

Last raised

Jul 2020

Total raised

$28M

Investors

13

About Indigo Diabetes NV

Indigo Diabetes NV, founded in 2016 and headquartered in Gent, Belgium, develops monitoring systems for chronic diseases.Indigo Diabetes NV is dedicated to revolutionizing chronic disease management through its flagship product, the Continuous Multi-Metabolite Monitoring (CMM®) system. This innovative device, implanted beneath the skin, continuously measures metabolites such as glucose, ketones, and lactate using advanced silicon photonics technology. The device provides real-time data to users via the Indigo app.Indigo Diabetes NV generates revenue through direct-to-consumer sales and potential partnerships with healthcare providers. Their business model includes subscription services for ongoing support and software updates via the Indigo app, enhancing user engagement with their CMM® sensor. The company is working on new product designs to enhance its monitoring systems and aims to enter additional international markets by the end of 2023, targeting regions with significant chronic disease challenges.

Who invested in Indigo Diabetes NV

13 investors across 2 rounds

See all investors in Indigo Diabetes NV

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jul 24, 2020

    Amount

    $20M

    Investors

    Locked

  2. Series A

    Dec 20, 2016

    Amount

    $7.5M

    Investors

    Locked

Questions about Indigo Diabetes NV

Who invested in Indigo Diabetes NV?

Indigo Diabetes NV has 13 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Indigo Diabetes NV raised?

Indigo Diabetes NV has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Indigo Diabetes NV last raise money?

Indigo Diabetes NV's most recent round on record is a Series B, in Jul 2020.

What does Indigo Diabetes NV do?

Indigo Diabetes NV, founded in 2016 and headquartered in Gent, Belgium, develops monitoring systems for chronic diseases.

Where is Indigo Diabetes NV headquartered?

Indigo Diabetes NV is headquartered in Gent, Belgium.

Which VCs invest in companies like Indigo Diabetes NV?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at Indigo Diabetes NV's stage. Their profiles are linked below.

Raising like Indigo Diabetes NV? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.